United States· US:0023-4291_447257d6-c313-499e-8a48-499badb37766
LASTACAFT
A alcaftadine product containing alcaftadine, registered in United States by Allergan, Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- ALCAFTADINE
- Manufacturer
- Allergan, Inc.
- Country
- United States (US)
- ATC code
- S01GX11
- ATC class
- Alcaftadine
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 10
- ndc1100234291011 BOTTLE, PLASTIC in 1 CARTON (0023-4291-01) / 1 mL in 1 BOTTLE, PLASTIC
- ndc1100234291051 BOTTLE, PLASTIC in 1 CARTON (0023-4291-05) / 5 mL in 1 BOTTLE, PLASTIC
- ndc1100234291061 BOTTLE, PLASTIC in 1 CARTON (0023-4291-06) / 5 mL in 1 BOTTLE, PLASTIC
- ndc1100234291072 BOTTLE, PLASTIC in 1 CARTON (0023-4291-07) / 5 mL in 1 BOTTLE, PLASTIC
- ndc1100234291102 BOTTLE, PLASTIC in 1 CARTON (0023-4291-10) / 5 mL in 1 BOTTLE, PLASTIC
- ndc110023-4291-01
- ndc110023-4291-05
- ndc110023-4291-06
- ndc110023-4291-07
- ndc110023-4291-10
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under S01GX11
Alcaftadine, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ac86be2c-74ba-481c-8e83-8a0bcb181eec GET /v1/drugs/ac86be2c-74ba-481c-8e83-8a0bcb181eec?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "OPHTHALMIC",
"source": "ndc",
"strength": "2.5",
"substance": "ALCAFTADINE",
"productndc": "0023-4291",
"dosage_form": "SOLUTION/ DROPS",
"dea_schedule": null,
"strength_unit": "mg/mL",
"application_number": "NDA022134",
"marketing_category": "NDA"
}See everything about alcaftadine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.